These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 1373503)

  • 1. Cyclic AMP induces transforming growth factor beta 2 gene expression and growth arrest in the human androgen-independent prostate carcinoma cell line PC-3.
    Bang YJ; Kim SJ; Danielpour D; O'Reilly MA; Kim KY; Myers CE; Trepel JB
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3556-60. PubMed ID: 1373503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of TGF-beta-regulated interleukin-8 expression in human prostate cancer cells.
    Lu S; Dong Z
    Prostate; 2006 Jun; 66(9):996-1004. PubMed ID: 16541418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic AMP distinguishes between two functions of acidic FGF in a rat bladder carcinoma cell line.
    Boyer B; Thiery JP
    J Cell Biol; 1993 Feb; 120(3):767-76. PubMed ID: 7678836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opposite and independent actions of cyclic AMP and transforming growth factor beta in the regulation of type 1 plasminogen activator inhibitor expression.
    Thalacker FW; Nilsen-Hamilton M
    Biochem J; 1992 Nov; 287 ( Pt 3)(Pt 3):855-62. PubMed ID: 1332686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine 3',5'-monophosphate and phorbol ester induce transforming growth factor-beta 1 messenger ribonucleic acid levels in choriocarcinoma cells.
    Ritvos O; Erämaa M
    Endocrinology; 1991 Oct; 129(4):2240-5. PubMed ID: 1655396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor beta 1 selectively increases gene expression of the serine/threonine kinase receptor 1 (SKR1) in human hepatoma cell lines.
    Inagaki M; Wang Z; Carr BI
    Cell Struct Funct; 1994 Oct; 19(5):305-13. PubMed ID: 7850892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of transforming growth factor beta 1 on the adenylyl cyclase-cAMP pathway in prostate cancer.
    Steiner MS; Wand GS; Barrack ER
    Growth Factors; 1994; 11(4):283-90. PubMed ID: 7779408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of progesterone receptor gene expression in MCF-7 breast cancer cells: a comparison of the effects of cyclic adenosine 3',5'-monophosphate, estradiol, insulin-like growth factor-I, and serum factors.
    Cho H; Aronica SM; Katzenellenbogen BS
    Endocrinology; 1994 Feb; 134(2):658-64. PubMed ID: 7507831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of cyclic AMP and polypeptide growth regulators in growth inhibition by interferon in PC-3 cells.
    Okutani T; Nishi N; Kagawa Y; Takasuga H; Takenaka I; Usui T; Wada F
    Prostate; 1991; 18(1):73-80. PubMed ID: 1846237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor beta 1 inhibits gonadotropin action in cultured porcine Sertoli cells.
    Morera AM; Esposito G; Ghiglieri C; Chauvin MA; Hartmann DJ; Benahmed M
    Endocrinology; 1992 Feb; 130(2):831-6. PubMed ID: 1370796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of the receptor for parathyroid hormone (PTH) and PTH-related peptide by transforming growth factor-beta in primary fetal rat osteoblasts.
    Jongen JW; Willemstein-Van Hove EC; Van der Meer JM; Bos MP; Jüppner H; Segre GV; Abou-Samra AB; Feyen JH; Herrmann-Erlee MP
    Endocrinology; 1995 Aug; 136(8):3260-6. PubMed ID: 7628359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The phosphodiesterase inhibitor, pentoxifylline, alters rat intestinal epithelial cell proliferation via changes in the expression of transforming growth factors.
    Diab-Assef M; Reimund JM; Ezenfis J; Duclos B; Kedinger M; Foltzer-Jourdainne C
    Scand J Gastroenterol; 2002 Feb; 37(2):206-14. PubMed ID: 11843059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: implications for prostate cancer progression.
    Cox ME; Deeble PD; Lakhani S; Parsons SJ
    Cancer Res; 1999 Aug; 59(15):3821-30. PubMed ID: 10447001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor beta alters the expression of heparan sulfate proteoglycan in human colon carcinoma cells.
    Dodge GR; Kovalszky I; Hassell JR; Iozzo RV
    J Biol Chem; 1990 Oct; 265(29):18023-9. PubMed ID: 1698783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of expression and regulation of transforming growth factor beta in human cancer prostate cell lines.
    Blanchère M; Saunier E; Mestayer C; Broshuis M; Mowszowicz I
    J Steroid Biochem Mol Biol; 2002 Nov; 82(4-5):297-304. PubMed ID: 12589936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-2 microglobulin is mitogenic to PC-3 prostatic carcinoma cells and antagonistic to transforming growth factor beta 1 action.
    Rowley DR; Dang TD; McBride L; Gerdes MJ; Lu B; Larsen M
    Cancer Res; 1995 Feb; 55(4):781-6. PubMed ID: 7850789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormonal regulation of transforming growth factor beta-2 expression in human prostate cancer.
    Knabbe C; Klein H; Zugmaier G; Voigt KD
    J Steroid Biochem Mol Biol; 1993 Dec; 47(1-6):137-42. PubMed ID: 8274428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. cAMP influence on transcription of thrombomodulin is dependent on de novo synthesis of a protein intermediate: evidence for cohesive regulation of myogenic proteins in vascular smooth muscle.
    Traynor AE; Cundiff DL; Soff GA
    J Lab Clin Med; 1995 Sep; 126(3):316-23. PubMed ID: 7665981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice.
    Zhang F; Lee J; Lu S; Pettaway CA; Dong Z
    Clin Cancer Res; 2005 Jun; 11(12):4512-20. PubMed ID: 15958637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.
    Sokoloff MH; Tso CL; Kaboo R; Taneja S; Pang S; deKernion JB; Belldegrun AS
    Cancer; 1996 May; 77(9):1862-72. PubMed ID: 8646686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.